MedPath
Found 2 clinical trials|View Analysis
Sort by:

Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer

Phase 1
Terminated
Conditions
Colorectal Neoplasm
Interventions
First Posted Date
2015-03-10
Last Posted Date
2022-04-08
Lead Sponsor
GSO Global Clinical Research BV
Target Recruit Count
10
Registration Number
NCT02384850
Locations
🇧🇪

University Hospital Antwerpen, Antwerpen, Belgium

🇩🇪

University Hospital Hamburg, Hamburg, Germany

A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Phase 2
Completed
Conditions
Acute Myeloid Leukemia (Relapsed/Refractory)
Interventions
First Posted Date
2014-09-25
Last Posted Date
2021-08-25
Lead Sponsor
GSO Global Clinical Research BV
Target Recruit Count
42
Registration Number
NCT02249091
Locations
🇩🇪

Universitätsklinikum Frankfurt, Frankfurt am Main, Hessen, Germany

🇩🇪

Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

🇩🇪

Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany

© Copyright 2025. All Rights Reserved by MedPath